A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes Mellitus

NCT00630825 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

262

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: LY2189265
DRUG: Placebo

Sponsor

Eli Lilly and Company